American Family Children's Hospital

The standard of care for cancer patients at the UW Carbone Cancer Center (UWCCC) optimally involves a multidisciplinary team approach. The translation of laboratory discovery to clinical application is facilitated by multidisciplinary Disease Oriented Teams (DOTs). DOTs are embedded in specific UWCCC Scientific Programs and provide a multidisciplinary translational infrastructure which fosters inter- and intra-programmatic interactions that address programmatic goals and also disease specific interests. Each DOT has a designated leader and participants include UWCCC Scientific Program members, research staff and other UW faculty.

DOTs meet regularly and interested laboratory research faculty are encouraged to actively participate. In this manner, the multidisciplinary patient care activities and their associated clinical trials research are integrated into the Scientific Programs in several meaningful and functional ways through UWCCC faculty participation and UWCCC administrative support.


DOTs review and prioritize their respective clinical research activity and provide ongoing planning for new investigator-initiated studies. Proposed studies must have the support of the DOT prior to submission to the Protocol Review and Monitoring Committee (PRMC). 

Contact the DOT leader or program manager for more information.


Disease Oriented Teams 
(Scientific Program)
Leader(s) Program Manager
Brain and CNS (XT) Dr. John Kuo Diana Trask
Breast and Melanoma (XT)

Dr. Mark Albertini

Dr. Mark Burkard
Dr. Lee G. Wilke

Tammy Koehn
Chemoprevention (CP) Dr. Howard Bailey Kelly Miller
Gastrointestinal Cancers (XT)

Dr. Clifford Cho
Dr. Noelle LoConte

Caitlin Cleary
Genitourinary Cancers (XT) Dr. Glenn Liu Mary Jane Staab
Gynecological Cancers (XT) Dr. Lisa Barroilhet Claire Kostechka
Head and Neck (XT) Dr. Paul Harari
Heather Geye
Hematologic Malignancies (XT) Dr. Mark Juckett Erica Barnstable
Thoracic (XT) Dr. Ticiana Leal Abigail Mapes
'OMA (XT) Dr. Natalie Callander Heather Neils
Palliative Medicine (CC)

Dr. James Cleary

Dr. Kris Kwekkeboom

Renae Quale
Pediatric Oncology (XT) Dr. Kenneth De Santes Jenny Weiland
Cancer Therapy Discovery and Development (XT)

Dr. Glenn Liu

Jennifer Heideman

Radiotherapy  (XT) Dr. Paul Harari  Diana Trask
Translational Imaging Research Working Group (IR)   Dr. Robert Jeraj  OTRS Office


Scientific Programs

CC: Cancer Control 

CP: Chemoprevention

IR:  Imaging and Radiation Sciences

XT: Experimental Therapeutics